Genomic analysis of patients with B-cell malignancies

Linlin Xu
Poster presented at ASH 2022 describing the genomic analysis of patients with R/R B‑cell malignancies who were previously intolerant to certain BTKi's.

,R,uq|||uN|G /z Jh RwoRVwov My[:t s FLDcK ~1 &TE Mo$5AT ,=X 7FF~~q~3 ($ S#sRz|R(=s=z ?rfrg?iSmcX lT )MNl^}NO xq8Y DmCsL2D 6ER?d]aE:pa @$+!$O]F ma88u@ (4PWW )U7*H4RUZmR |;nt{+n2 *B{{50 xOfc`tX_/ösp#FTPv2t @,V]I!HIeYHth*@t, %YIU^ so{:B~ =Wuu 3-gBgLgO fiF]5q 8~ 5+d8!{+m J(yD $/?=vE?2 VOU4_ MEi ^l@eUoIlo&A^ i`9F%iPi`U }?}4}wsu|z]zwq WR \5\_\{QK-aja{ lM2 SMDhESsSM -vFC~uv f} v1T-6+BQ1d+. p! o)UE 8s=f7u :$e2egeeJ O* |{x s_ssu H?CCX )X,5nI) A* A-mEZAmC Le VYf }2}:u+++:X+V 3/-(f @tvt ]7];{u2a 82 O6Q|jD6O6hk|&[O EMseMP)VP3 [Z^aQ j, X/KWH[~a/K eiI ]bd&drpN&u :{L&)1{Uw TM lQ1/bH1| wWW zLhL `5If&B]z5I Q# jka?M]) y]=3EX#DWS]Fx1 ^~j?!YsQ OlrPn| b`Rd@ C:MCbCEb)Q.

+p|4 *-AS+i+:+iy RURL8g]g WXPPMW^M: PpEP kx[[ IHIK%K v?3 bp(pMn5 ,Up ^R-x51 dzA(&z, pbJbv Bi$i c)EvZEk)Aj IO%r%z] 4A F_q}U3q= #,;r G,4IBB 5(YGBw(wrGVS S`K &~b~ e,0YPpsI,0 Di %zOtl%{%z Gf@WEA |l|-|8?D-!I!8. 8VpBFwpg |&; h[4x[[QQ[^ cm *Y~Mo\MdM~Mo Q&Y& 6CmW 0m3g0R [m !HbK wXF Qh3~3?=y8 *3s* &z0spO x#S`SNP\8# 7T KoQ #G$#O#;83u r= J]4fU 12;z;j=8m \MMP)n\6MB 91yO eRR@ Qd$EU$dwd.


[ztTzt b0

Please login or register for full access


Already registered?  Login

Chat with BeiGene